certican 1,0 mg tabletes
novartis baltics, sia, latvia - everolims - tablete - 1,0 mg
certican 0,25 mg disperģējamās tabletes
novartis baltics, sia, latvija - everolims - disperģējamā tablete - 0,25 mg
certican 0,1 mg disperģējamās tabletes
novartis baltics, sia, latvija - everolims - disperģējamā tablete - 0,1 mg
certican 0,75 mg tabletes
novartis baltics, sia, latvia - everolims - tablete - 0,75 mg
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - pretvīrusu līdzekļi sistēmiskai lietošanai - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - immunosuppressants, selektīvi immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
bozilos 14 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - teriflunomīds - apvalkotā tablete - 14 mg
terebyo 14 mg apvalkotās tabletes
sandoz d.d., slovenia - teriflunomīds - apvalkotā tablete - 14 mg